colon_cancer | R Documentation |
Meta-analysis of 7 RCTs, 4 cRWE studies, and 2 matched sRWE studies evaluating progression-free survival (PFS) as a surrogate endpoint to overall survival (OS) in metastatic colorectal cancer (mCRC), comparing antiangiogenic treatments with chemotherapy.
A dataframe with 13 rows and 6 columns. Each row represents study results, the columns are:
Author and year.
randomized clinical trial or comparative/single-arm real-world-evidence
logarithm of hazard ratios of progression-free survival
standard error of pfs
logarithm of hazard ratios of overall survival
standard error of os
Wheaton L, Papanikos A, Thomas A, Bujkiewicz S. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation. Medical Decision Making. 2023;43(5):539-552. doi:10.1177/0272989X231162852
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.